Pure Bioscience (PURE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 07/31
| 04-2001 | 01-2001 | 10-2000 | 07-2000 | 04-2000 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 520 | 560 | 820 | 1,320 | 1,610 |
| Receivables | 400 | 280 | 300 | 440 | 1,010 |
| Inventories | 820 | 890 | 880 | 790 | 710 |
| Other current assets | 340 | 400 | 350 | 240 | 280 |
| TOTAL | $2,080 | $2,130 | $2,350 | $2,790 | $3,610 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 1,758 | 1,598 | 1,528 | 1,300 | 1,280 |
| TOTAL | $1,758 | $1,598 | $1,528 | $1,300 | $1,280 |
| Total Assets | $4,770 | $4,700 | $4,900 | $5,160 | $5,910 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 480 | 310 | 410 | 300 | 320 |
| Accrued Expenses | 50 | 40 | 50 | 30 | 50 |
| TOTAL | $730 | $560 | $660 | $550 | $630 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 40 | 60 | 70 |
| TOTAL | $N/A | $N/A | $40 | $60 | $70 |
| Total Liabilities | $730 | $560 | $710 | $610 | $710 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | 828 | N/A | N/A | N/A |
| Common Shares | 11,000 | 10,550 | 10,100 | 10,010 | 9,770 |
| Retained earnings | -7,070 | -6,520 | -6,020 | -5,580 | -4,670 |
| Other shareholders' equity | 110 | 110 | 100 | 110 | 100 |
| TOTAL | $4,040 | $4,140 | $4,180 | $4,540 | $5,200 |
| Total Liabilities And Equity | $4,770 | $4,700 | $4,890 | $5,150 | $5,910 |